Medical Innovation Exchange

Foghorn downgraded to full clinical hold, with more patient deaths clouding AML, MDS trial

https://www.fiercebiotech.com/biotech/fda-tacks-full-clinical-hold-foghorn-trial-clouded-more-patient-deaths

Leave a Comment

Your email address will not be published.

Leave the field below empty!